Sangamo Therapeutics (SGMO), Pfizer (PFE) Report Phase 1/2 Interim Data For Investigational Hemophilia A Gene Therapy
Tweet Send to a Friend
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) and Pfizer, Inc. (NYSE: PFE) today announced interim data from the Phase 1/2 Alta ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
